Actively Recruiting
Comparison of Application Effects Between Long- and Standard Short- Peripheral Venous Catheters
Led by Shenzhen Third People's Hospital · Updated on 2024-07-16
250
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Short PIVC (intravenous indentation needle) accounts for more than 50% of clinical infusion tools, but long PIVC is rarely used and studied in China. This study aims to explore the application characteristics and application effects of long PIVC in China. It provides reference for the correct selection of infusion tools, and promotes the clinical application and promotion of new intravenous therapy tools. The study nurse will work with the responsible physician to assess the eligibility for enrollment and sign the informed consent. Were randomly assigned to the control group (to receive a new 24G/22G (0.7mm\*19mm/0.9mm\*25mm) short PIVC (closed needle protected venous catheter system) puncture) or the intervention group (to insert a new 3F (8cm) or 4F(10cm) long PIVC) for daily routine maintenance until catheter removal, General demographic data, laboratory-related data, catheter-related data, catheter-related complications (unplanned extubation, phlebitis, catheter blockage, catheter-related thrombosis, catheter-related bloodstream infection, exudation, etc.) and patient satisfaction were collected.
CONDITIONS
Official Title
Comparison of Application Effects Between Long- and Standard Short- Peripheral Venous Catheters
Who Can Participate
Eligibility Criteria
You may qualify if you...
- A male or female aged 18 years or older who is able and willing to give written informed consent
- Patient's medical diagnosis confirmed by physician and study nurse during hospital stay
- Peripheral intravenous infusion therapy expected to last more than 4 days
- Good compliance and ability to cooperate with catheter maintenance and observation
You will not qualify if you...
- Patients who are delirious and unable to cooperate
- Patients requiring central venous access
- Patients suffering from connective tissue diseases or blood diseases
- Patients allergic to catheters or dressings
- Any condition deemed by the investigator to interfere with evaluation or pose health risks
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Deng Qiuxia
Shenzhen, Guangdong, China
Actively Recruiting
Research Team
Q
Qiuxia Deng
CONTACT
X
Xiaoning Liu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here